Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Thromboembolism, Venous

fluorodeoxyglucose f18 has been researched along with Thromboembolism, Venous in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's17 (85.00)24.3611
2020's3 (15.00)2.80

Authors

AuthorsStudies
Delluc, A; Robin, P1
Grewal, RK; Le Gal, G; Le Roux, PY; Robin, P; Salaun, PY1
Beckers, M; Le Gal, G; Le Roux, PY; Lecumberri, R; Robin, P; Rondina, M; Salaun, PY; van Es, N1
Couturaud, F; Le Gal, G; Le Moigne, E; Le Roux, PY; Merah, A; Pastre, J; Planquette, B; Prévot-Bitot, N; Robin, P; Roy, PM; Salaun, PY1
Lacut, K; Lavigne, C; Le Gal, G; Le Roux, PY; Merah, A; Pastre, J; Planquette, B; Prévot-Bitot, N; Robin, P; Salaun, PY1
Couturaud, F; Kumar, S; Le Gal, G; Le Roux, PY; Merah, A; Planquette, B; Robin, P; Roy, PM; Salaun, PY; Thavorn, K1
Alfonso, A; Del Olmo, B; García-Velloso, MJ; Lecumberri, R; Páramo, JA; Redondo, M; Richter, JA; Rodríguez-Wilhelmi, P; Rubio, T1
Bagni, O; Ciorra, A; Filippi, L; Sardella, B; Scopinaro, F1
Alavi, A; Chauhan, MS; Hess, S; Jacob, MJ; Ravina, M1
Alavi, A; Frifelt, JJ; Hess, S; Høilund-Carlsen, PF; Iversen, ED; Madsen, PH1
Abgral, R; Couturaud, F; Delluc, A; Le Gal, G; Le Roux, PY; Reffad, A; Robin, P; Salaun, PY; Tardy, B1
Batra, S; Karanth, SS; Sharma, D; Vaid, AK1
Basu, S; Hansson, SH; Hess, S; Høilund-Carlsen, PF; Pedersen, KT1
Alavi, A; Goris, ML; Hess, S; Rubello, D; Zhu, HJ1
Accassat, S; Couturaud, F; Couturier, O; Delluc, A; Ghazzar, N; Le Gal, G; Le Roux, PY; Planquette, B; Prevot-Bitot, N; Robin, P; Roy, PM; Salaun, PY; Sanchez, O; Tardy, B1
Chen, L; Luo, Q; Shen, Y; Wu, X1
Gupta, A; Jeph, S; Karunanithi, S; Kumar, R; Malhotra, A; Naswa, N; Sharma, P1
Heilbrun, M; Hoffman, JM; Kraiss, LW; Morton, KA; Pendleton, RC; Rondina, MT; Vinik, R; Wanner, N; Zimmerman, GA1
Bal, C; Jeph, S; Kumar, R; Malhotra, A; Naswa, N; Patnecha, M; Reddy, RM; Sharma, P; Singh, H1
Alavi, A; Basu, S; Hess, S; Høilund-Carlsen, PF; Madsen, PH1

Reviews

2 review(s) available for fluorodeoxyglucose f18 and Thromboembolism, Venous

ArticleYear
Performance of
    Thrombosis research, 2020, Volume: 194

    Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Venous Thromboembolism

2020
FDG-PET/CT in Infectious and Inflammatory Diseases.
    PET clinics, 2014, Volume: 9, Issue:4

    Topics: Arthritis, Rheumatoid; Bacterial Infections; Bone Diseases; Endocarditis; Fluorodeoxyglucose F18; Humans; Immunocompromised Host; Inflammation; Inflammatory Bowel Diseases; Multimodal Imaging; Positron-Emission Tomography; Psoriasis; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed; Vasculitis; Venous Thromboembolism

2014

Trials

3 trial(s) available for fluorodeoxyglucose f18 and Thromboembolism, Venous

ArticleYear
Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
    Thrombosis research, 2017, Volume: 155

    Topics: Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Venous Thromboembolism

2017
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
    Thrombosis research, 2018, Volume: 171

    Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Ontario; Patient Acceptance of Health Care; Positron Emission Tomography Computed Tomography; Quality-Adjusted Life Years; Venous Thromboembolism

2018
Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
    The Lancet. Oncology, 2016, Volume: 17, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Intention to Treat Analysis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thromboembolism; Whole Body Imaging

2016

Other Studies

15 other study(ies) available for fluorodeoxyglucose f18 and Thromboembolism, Venous

ArticleYear
    Thrombosis research, 2022, Volume: 213 Suppl 1

    Topics: Electrons; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thromboembolism

2022
Interobserver agreement of
    Thrombosis research, 2020, Volume: 188

    Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasms; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Venous Thromboembolism

2020
Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Venous Thromboembolism

2017
Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
    International journal of cancer, 2013, Volume: 133, Issue:9

    Topics: Aged; Anticoagulants; Biomarkers, Tumor; Blood Coagulation Factors; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thromboembolism

2013
Tumor thrombus in the renal vein from an adrenal metastasis of lung cancer: 18FDG PET/CT findings.
    Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:5

    Topics: Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Renal Veins; Tomography, X-Ray Computed; Venous Thromboembolism

2014
Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:9

    Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Child; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms; Portal Vein; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thrombosis; Tomography, X-Ray Computed; Veins; Vena Cava, Inferior; Venous Thromboembolism; Young Adult

2014
Efficacy of FDG PET/CT imaging for venous thromboembolic disorders: preliminary results from a prospective, observational pilot study.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:1

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Venous Thromboembolism; Venous Thrombosis

2015
Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism.
    Thrombosis research, 2015, Volume: 135, Issue:1

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Multimodal Imaging; Perfusion; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Venous Thromboembolism

2015
Mediastinal germ cell tumour causing superior vena cava tumour thrombosis.
    BMJ case reports, 2015, Mar-25, Volume: 2015

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chest Pain; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Heparin, Low-Molecular-Weight; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Testicular Neoplasms; Treatment Outcome; Vena Cava, Superior; Venous Thromboembolism

2015
The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism.
    Nuclear medicine communications, 2016, Volume: 37, Issue:3

    Topics: Biological Transport; Fluorodeoxyglucose F18; Humans; Lower Extremity; Positron-Emission Tomography; Retrospective Studies; Veins; Venous Thromboembolism

2016
Anatomic and metabolic imaging of venous thromboembolism mimicking thyroid carcinoma extension.
    Journal of thrombosis and thrombolysis, 2010, Volume: 29, Issue:3

    Topics: Adenocarcinoma, Follicular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Venous Thromboembolism

2010
18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?
    Nuclear medicine communications, 2011, Volume: 32, Issue:9

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Venous Thromboembolism; Young Adult

2011
A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.
    Thrombosis research, 2012, Volume: 129, Issue:1

    Topics: Adult; Aged; Cost-Benefit Analysis; Early Detection of Cancer; Feasibility Studies; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Insurance, Health, Reimbursement; Male; Mass Screening; Medicare; Middle Aged; Multimodal Imaging; Neoplasms; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; United States; Utah; Venous Thromboembolism; Whole Body Imaging

2012
Imaging thrombus in cancer patients with FDG PET-CT.
    Japanese journal of radiology, 2012, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms; Neoplastic Cells, Circulating; Positron-Emission Tomography; Radiopharmaceuticals; Thrombosis; Tomography, X-Ray Computed; Vena Cava, Inferior; Venous Thromboembolism; Young Adult

2012
Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:12

    Topics: Animals; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Venous Thromboembolism

2012